Cirrhosis
Cirrhosis is advanced liver fibrosis associated with progressive loss of liver function and complications such as portal hypertension and liver failure. Laboratory testing helps assess liver function, complications, underlying causes, and disease severity.
Liver enzymes may be normal or only mildly abnormal even in advanced liver disease — cirrhosis assessment may require blood tests, imaging, fibrosis assessment, and clinical evaluation together, not blood tests alone.
At National Path Lab (NPL), comprehensive testing is available to support the evaluation of suspected or known cirrhosis, including underlying cause investigation and complication screening.
- Tests available
- 5
- Tests available
- Health package
- 1
- Health package
Tests Available at NPL
LIVER FUNCTION TEST PANEL 1
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 1000
COMPLETE BLOOD COUNT
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 500
ALPHAFETOPROTEIN; AFP, TUMOR MARKER
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 1500
GFR (GLOMERULAR FILTRATION RATE), ESTIMATED
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 600
PROTHROMBIN TIME; PT INR
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY
Rs. 500
About Cirrhosis
Causes & Risk Factors
Cirrhosis represents the end stage of various chronic liver diseases, most commonly:
• Chronic viral hepatitis (hepatitis B or C) — major causes of cirrhosis worldwide.
• MASLD/fatty liver disease — an increasingly common cause of cirrhosis.
• Alcohol-associated liver disease.
• Autoimmune liver diseases, including autoimmune hepatitis and primary biliary cholangitis.
• Other less common causes, including certain inherited metabolic liver conditions.
Symptoms & When to Test
Cirrhosis symptoms often develop gradually and may not appear until the disease is relatively advanced (compensated cirrhosis can be asymptomatic).
• Fatigue
• Abdominal swelling (ascites) in more advanced disease
• Jaundice
• Easy bruising or bleeding, related to impaired clotting factor production
• Swelling in the legs
• Confusion or altered mental status, in advanced disease (hepatic encephalopathy)
• Often asymptomatic in earlier (compensated) stages
When Should You Consider Testing?
Evaluation is appropriate for known chronic liver disease requiring monitoring, symptoms suggestive of liver dysfunction, or when cirrhosis is suspected based on imaging or other clinical findings.
Why Tests Are Combined
Because liver enzymes alone can be normal or only mildly abnormal even in advanced cirrhosis, a broader panel — CBC (anemia, platelet count), bilirubin, albumin, and PT/INR (synthetic function) — together provides a more complete picture of how well the liver is actually functioning, beyond just detecting ongoing injury.
Creatinine/eGFR and sodium are included because advanced cirrhosis can be associated with kidney dysfunction and fluid/electrolyte abnormalities, which are important both for assessing severity and for guiding management of complications.
Viral hepatitis markers and, where appropriate, AFP for hepatocellular carcinoma surveillance address the underlying cause and a serious potential complication of cirrhosis respectively — identifying a treatable underlying cause and monitoring for cancer risk are both essential parts of comprehensive cirrhosis care.
Tests Available at NPL
Test Code | Test | Clinical Relevance |
H0012
| CBC | Evaluates anemia, leukocyte abnormalities, and platelet count. |
B0046 | LIVER FUNCTION TEST PANEL 1 | Evaluates liver injury, jaundice and bilirubin metabolism. Assesses bilirubin metabolism and excretory function. |
H0031 | PT / INR | Evaluates coagulation and provides information about hepatic synthetic function. |
B0035 | Creatinine / eGFR | Assesses kidney function, important in advanced liver disease. |
| Viral Hepatitis Markers | Help identify hepatitis B or C as potential underlying causes. |
I0005 | AFP | May be used as part of hepatocellular carcinoma surveillance in appropriate patients, generally together with imaging. |
Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.
Home Sample Collection
NPL offers convenient home sample collection for Cirrhosis blood tests, so you don't need to visit a lab in person.
→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.
→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.
→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.
→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.
When to See a Doctor
• Known chronic liver disease requiring monitoring
• Unexplained abdominal swelling
• Jaundice, easy bruising, or leg swelling
• Confusion or altered mental status with known liver disease — seek prompt evaluation
• Cirrhosis suspected based on imaging findings
Medical Disclaimer Laboratory tests support the assessment of cirrhosis but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional. |
